Lungpacer Medical, Inc. Presents at Respiratory Innovation Summit, May 2018, San Francisco, California

May 1, 2018

Lungpacer Medical Inc. was invited to present at the inaugural RIS meeting in San Francisco, CA. The Respiratory Innovation Summit unites the innovators, investors and clinicians who are leading the fight to create powerful new treatments for deadly and crippling diseases of the lungs and airways. Lungpacer CEO, Doug Evans, presented preclinical research utilizing Lungpacer’s novel phrenic nerve pacing technology at the 2018 RIS Meeting.